Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
Clinical trial NCT00576056 · TERMINATED
Trial details
- NCT number
- NCT00576056
- Sponsor
- University of Pittsburgh
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-03-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.